{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T07:45:22Z","timestamp":1750491922735,"version":"3.37.3"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T00:00:00Z","timestamp":1697760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T00:00:00Z","timestamp":1697760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Hisamitsu Pharmaceutical Co., Inc."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pain Ther"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s40122-023-00558-2","type":"journal-article","created":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T21:01:34Z","timestamp":1697835694000},"page":"1439-1454","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Combined Efficacy of Systemically Acting Diclofenac Sodium Patch and Alpha-2-Delta Calcium Channel Ligand in Chronic Low Back Pain: Subanalysis of a Phase III Study"],"prefix":"10.1007","volume":"12","author":[{"given":"Shigeki","family":"Yamaguchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaaki","family":"Terahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Okawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9771-797X","authenticated-orcid":false,"given":"Hiroshi","family":"Inakura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,20]]},"reference":[{"key":"558_CR1","volume-title":"Clinical practice guidelines on the management of low back pain","author":"The Japanese Orthopaedic Association. Japanese Orthopaedic Association (JOA)","year":"2019","unstructured":"The Japanese Orthopaedic Association. Japanese Orthopaedic Association (JOA). Clinical practice guidelines on the management of low back pain. 2nd ed. Tokyo: Nankodo Co. Ltd.; 2019.","edition":"2"},{"issue":"4","key":"558_CR2","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1177\/1742395313476901","volume":"9","author":"S Snelgrove","year":"2013","unstructured":"Snelgrove S, Liossi C. Living with chronic low back pain: a metasynthesis of qualitative research. Chronic Illn. 2013;9(4):283\u2013301.","journal-title":"Chronic Illn"},{"key":"558_CR3","unstructured":"Health, Labour and Welfare Policy Research Grants (Research on chronic pain) in Japan: Research for the Uniform Accessibility to Chronic Pain Management Systems and Improved Healthcare Utilizing Pain Center Treatment Databases. Clinical practice guideline for the management chronic pain. 1st ed. Tokyo: Shinko Trading Co., Ltd.; 2021."},{"issue":"10","key":"558_CR4","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1185\/03007995.2011.619431","volume":"27","author":"B Morlion","year":"2011","unstructured":"Morlion B. The relevance of neuropathic components in chronic back pain. Curr Med Res Opin. 2011;27(10):2067\u20138.","journal-title":"Curr Med Res Opin"},{"issue":"5","key":"558_CR5","first-page":"422","volume":"30","author":"AM Kaki","year":"2005","unstructured":"Kaki AM, El-Yaski AZ, Youseif E. Identifying neuropathic pain among patients with chronic low-back pain: use of the Leeds Assessment of Neuropathic Symptoms and Signs pain scale. Reg Anesth Pain Med. 2005;30(5):422\u20138.","journal-title":"Reg Anesth Pain Med"},{"key":"558_CR6","unstructured":"National Guideline Centre (UK). Low back pain and sciatica in over 16s: assessment and management. 2016. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK401577\/. Accessed 14 April July 2023."},{"issue":"7","key":"558_CR7","doi-asserted-by":"publisher","first-page":"514","DOI":"10.7326\/M16-2367","volume":"166","author":"A Qaseem","year":"2017","unstructured":"Qaseem A, Wilt TJ, McLean RM, et al. Noninvasive treatments for acute, subacute, and chronic low back pain: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2017;166(7):514. https:\/\/doi.org\/10.7326\/M16-2367.","journal-title":"Ann Intern Med"},{"issue":"12","key":"558_CR8","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1007\/s00586-010-1502-y","volume":"19","author":"BW Koes","year":"2010","unstructured":"Koes BW, van Tulder M, Lin CW, Macedo LG, McAuley J, Maher C. An updated overview of clinical guidelines for the management of non-specific low back pain in primary care. Eur Spine J. 2010;19(12):2075\u201394.","journal-title":"Eur Spine J"},{"issue":"1","key":"558_CR9","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/pme.12229","volume":"15","author":"DA Fishbain","year":"2014","unstructured":"Fishbain DA, Cole B, Lewis JE, Gao J. What is the evidence that neuropathic pain is present in chronic low back pain and soft tissue syndromes? An evidence-based structured review. Pain Med. 2014;15(1):4\u201315.","journal-title":"Pain Med"},{"issue":"4","key":"558_CR10","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s10195-009-0077-z","volume":"10","author":"CL Roman\u00f2","year":"2009","unstructured":"Roman\u00f2 CL, Roman\u00f2 D, Bonora C, Mineo G. Pregabalin, celecoxib, and their combination for treatment of chronic low-back pain. J Orthop Traumatol. 2009;10(4):185\u201391.","journal-title":"J Orthop Traumatol"},{"issue":"4","key":"558_CR11","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1007\/s40122-022-00437-2","volume":"11","author":"AB Yeole","year":"2022","unstructured":"Yeole AB, Lakshmi GSR, Selvakumar CJ, et al. Efficacy and safety of pregabalin prolonged release-etoricoxib combination compared to etoricoxib for chronic low back pain: phase 3, randomized study. Pain Ther. 2022;11(4):1451\u201369.","journal-title":"Pain Ther"},{"issue":"7","key":"558_CR12","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1185\/03007995.2010.486301","volume":"26","author":"TJ Gan","year":"2010","unstructured":"Gan TJ. Diclofenac: an update on its mechanism of action and safety profile. Curr Med Res Opin. 2010;26(7):1715\u201331.","journal-title":"Curr Med Res Opin"},{"issue":"2","key":"558_CR13","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s40122-023-00478-1","volume":"12","author":"T Taguchi","year":"2023","unstructured":"Taguchi T, Yamaguchi S, Terahara T, Okawa K, Inakura H. Systemically acting diclofenac sodium patch for control of low back pain: a randomized, double-blind, placebo-controlled study in Japan. Pain Ther. 2023;12(2):529\u201342.","journal-title":"Pain Ther"},{"issue":"4","key":"558_CR14","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1007\/s40122-022-00410-z","volume":"11","author":"T Nikaido","year":"2022","unstructured":"Nikaido T, Takatsuna H, Tabata S, Shiosakai K, Nakatani T, Konno SI. Efficacy and safety of add-on mirogabalin to NSAIDs in lumbar spinal stenosis with peripheral neuropathic pain: a randomized, open-label study. Pain Ther. 2022;11(4):1195\u2013214.","journal-title":"Pain Ther"},{"issue":"2","key":"558_CR15","first-page":"213","volume":"50","author":"T Taguchi","year":"2022","unstructured":"Taguchi T, Yamaguchi S, Terahara T, Okawa K, Inakura H, Nohara Y. Safety of long-term administration of a systemic-acting diclofenac sodium patch (HP-3150) in Japanese patients with low back pain. Jpn Pharmacol Ther. 2022;50(2):213\u201327.","journal-title":"Jpn Pharmacol Ther"},{"issue":"3","key":"558_CR16","first-page":"341","volume":"51","author":"H Fukase","year":"2023","unstructured":"Fukase H, Futagami S, Yamamoto T, et al. An endoscopic study of the influence of a systemic patch containing diclofenac sodium on the upper gastrointestinal mucosa in healthy middle-aged and elderly men and women\u2014a randomized controlled trial with patent drug control. Jpn Pharmacol Ther. 2023;51(3):341\u201350 (translated from Japanese).","journal-title":"Jpn Pharmacol Ther"}],"container-title":["Pain and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40122-023-00558-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40122-023-00558-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40122-023-00558-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T07:19:26Z","timestamp":1698650366000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40122-023-00558-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,20]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["558"],"URL":"https:\/\/doi.org\/10.1007\/s40122-023-00558-2","relation":{},"ISSN":["2193-8237","2193-651X"],"issn-type":[{"type":"print","value":"2193-8237"},{"type":"electronic","value":"2193-651X"}],"subject":[],"published":{"date-parts":[[2023,10,20]]},"assertion":[{"value":"30 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Shigeki Yamaguchi received medical consultant fees from Hisamitsu Pharmaceutical Co., Inc. Shigeki Yamaguchi received honoraria from The Nakatomi Foundation. Takaaki Terahara, Koji Okawa, and Hiroshi Inakura are employees of Hisamitsu Pharmaceutical Co., Inc., Tokyo, Japan.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The phase III study was conducted in compliance with the Declaration of Helsinki of 1964 and its later amendments and Good Clinical Practice guidelines. The 75 participating institutions acquired approval of the protocol from one of the following institutional review boards: Shinagawa East One Medical Clinic Institutional Review Board, Sugiura Clinic Institutional Review Board, and Jimbo Orthopedics Institutional Review Board. Prior to enrollment, all participants provided written informed consent to participate in the study. Throughout the study period, no ethical problems or medical malpractice occurred, and the participants\u2019 identities were kept confidential. The phase III study was registered with the Japan Primary Registries Network (JPRN) as JPRN-JapicCTI-205134 and the Japan Registry for Clinical Trials (jRCT) as jRCT2080225040.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}